Boehringer Ingelheim Launches Hepatitis C Online Resource
RIDGEFIELD, Conn., Nov. 9, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of HepCRedefined.com, an online portal to help improve the lives of those living with the hepatitis C virus (HCV) through education, information and understanding. HepCRedefined.com aims to redefine the HCV journey by providing downloadable and shareable resources to healthcare providers, advocates, caregivers and patients.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/58946-boehringer-ingelheim-launches-hepatitis-c-online-resource
In order to bring together information that is most relevant to those impacted by HCV, the portal was developed in close collaboration with HCV community advocates as well as healthcare practitioners who are currently treating HCV patients. Resources available on the portal can be shared via social media channels, embedded on other web sources and viewed on various smart devices.
HCV is an infectious disease of the liver and is a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally. Since 1999 there has been a significant increase in deaths due to chronic HCV, accounting for 15,000 deaths in the United Sates in 2007.
Related PRNewswire Releases News